Questions a plan sponsor actually asks.
What is Insulin Glargine and Lixisenatide used for?
Insulin Glargine and Lixisenatide replaces or supplements natural insulin to control blood sugar in diabetes.
Is there a generic for Insulin Glargine and Lixisenatide?
No. Insulin Glargine and Lixisenatide is brand-only with no generic equivalents currently in market.
How much does my plan pay for Insulin Glargine and Lixisenatide?
Across 329 Part D plans, Insulin Glargine and Lixisenatide averages $57.05/unit (NADAC). Lowest available: $57.05/unit. Highest in distribution: $57.05/unit.
Is Insulin Glargine and Lixisenatide on the FDA shortage list?
No. Insulin Glargine and Lixisenatide is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.